Investing

Jp Cortez: Gold, Silver in Sound Money Renaissance, Bullish on Prices and Progress

He highlighted that seven states in the country passed various types of sound money legislation. Some removed taxes on precious metals, while others reaffirmed gold and silver as legal tender.

Utah went further, allowing for a US$180 million investment in gold to be stored on the state’s balance sheet.

‘We talk a lot about BRICS right now and de-dollarization, and there’s so much talk about countries with an adversarial relationship to the US who are looking for alternatives,’ said Cortez.

‘But if we look more closely, we’ll see it’s more than that. States themselves are also looking to de-dollarize — they’re looking for an alternative to dollar-denominated investments. We’re seeing that of course individuals, but (also) states, countries and international coalitions, seem to be coalescing around gold.’

He also outlined areas of focus for 2025, saying he hopes to see more progress on ending sales taxes on precious metals.

Overall, Cortez is positive on advocacy efforts for sound money, as well as on gold and silver prices.

‘I think we’re seeing that sound money — gold and silver — is having a renaissance right now,’ he said.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version